No Proof Required
Teva QVAR Inhaler $35M Antitrust Class Action Settlement
By the Class Action Buddy Editorial Team · Last reviewed July 23, 2026 · ✓ verified against the official QVARAntitrustSettlement.com notice and ClassAction.org reporting
Looking for a settlement you can still file?
This one is closed, but our 60-second eligibility quiz finds the ones that are still open.
Who Was Eligible?
Who the settlement covered:
- You are a consumer or entity (health plan) that purchased or reimbursed some or all of the cost of QVAR or QVAR Redihaler between January 1, 2015 and July 31, 2025.
- Buyers in 43 states are eligible to file.
How Much Did It Pay?
Cash payments come from the $35 million fund based on what you paid for QVAR products. Class members with proof of purchase receive a larger share of the net fund; those without proof receive a smaller share. Final amounts depend on total valid claims and deductions for fees and costs.
How this claim was filed
This settlement is closed, so the steps below are kept for reference only — they no longer lead anywhere you can file.
- Confirm eligibility — you bought or reimbursed QVAR/QVAR Redihaler between Jan 1, 2015 and July 31, 2025 in an eligible state.
- File by July 31, 2026 at the official site, QVARAntitrustSettlement.com.
- Proof is optional but valuable — pharmacy records, receipts, or an explanation of benefits showing your QVAR purchases qualify you for a larger payment. You can still file without proof for a smaller share.
- Filing is free. (Exclusion/objection deadline was June 15, 2026; final approval hearing Aug 5, 2026.)
Looking for something you can still claim?
This one has closed, but the open settlements list is kept current, and Class Action Buddy will tell you when a new one matches your profile.
Frequently Asked Questions
What is the deadline to file a claim for the Teva QVAR Inhaler $35M Antitrust Class Action Settlement?
The deadline to file a claim was Jul 31, 2026, and it has passed. Claims are no longer accepted for this settlement.
Did I need proof of purchase for the Teva QVAR Inhaler $35M Antitrust Class Action Settlement?
No proof of purchase was required — claims could be made on a sworn statement, without receipts, photos, or product packaging.
Who qualifies for the QVAR settlement?
Consumers and health plans in 43 states that purchased or reimbursed QVAR or QVAR Redihaler inhalers between January 1, 2015 and July 31, 2025.
How much does it pay?
A cash share of the $35 million fund based on what you paid. Claimants with proof of purchase receive a larger share; those without proof receive a smaller share.
Do I need proof?
No — you can file without it for a smaller payment. Providing pharmacy records, receipts, or an explanation of benefits qualifies you for a larger share.
What is the deadline?
Claims must be submitted by July 31, 2026.
Primary source: official settlement administrator — qvarantitrustsettlement.com. The settlement details on this page were checked against the administrator’s official website.
Class Action Buddy is an independent directory and is not affiliated with, endorsed by, or sponsored by the settlement administrator or the court. This page is general information, not legal advice. See how we verify settlements.
This settlement has closed
The filing deadline for this one has passed, so no new claims are being accepted. Class Action Buddy tracks the settlements that are still open and tells you when a new one matches your profile.
See settlements that are open →Get Notified About New Settlements
We find new class action settlements every week. Get alerts so you never miss free money.
No spam. Unsubscribe anytime. We respect your privacy.